SUSMED, Inc.
4263.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | ¥10,260,390 | ¥9,097,634 | ¥8,939,201 | ¥8,002,344 |
| - Cash | ¥4,398,137 | ¥4,846,920 | ¥5,048,838 | ¥4,904,074 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥5,862,253 | ¥4,250,714 | ¥3,890,363 | ¥3,098,270 |
| Revenue | ¥462,988 | ¥342,577 | ¥530,654 | ¥316,873 |
| % Growth | 35.1% | -35.4% | 67.5% | – |
| Gross Profit | ¥450,724 | ¥330,850 | ¥522,666 | ¥306,499 |
| % Margin | 97.4% | 96.6% | 98.5% | 96.7% |
| EBITDA | -¥289,219 | -¥358,993 | -¥43,990 | -¥228,000 |
| % Margin | -62.5% | -104.8% | -8.3% | -72% |
| Net Income | -¥298,404 | -¥357,415 | -¥50,749 | -¥233,483 |
| % Margin | -64.5% | -104.3% | -9.6% | -73.7% |
| EPS Diluted | -17.77 | -21.41 | -3.09 | -15.9 |
| % Growth | 17% | -592.9% | 80.6% | – |
| Operating Cash Flow | -¥432,477 | -¥230,762 | ¥100,591 | -¥165,283 |
| Capital Expenditures | -¥4,316 | -¥9,277 | -¥18,189 | -¥12,612 |
| Free Cash Flow | -¥436,793 | -¥240,039 | ¥82,402 | -¥177,895 |